Market Overview

The UK economy is “turning a corner”, Chancellor George Osborne has said in a speech in London. Mr. Osborne cited “tentative signs of a balanced, broad based and sustainable...

Chinese industrial production data is due this morning. We look for the figures to show a slight acceleration to 9.8% y/y, from 9.7% y/y in July, confirming that the economy has stabilised and started...

Canada – Employment rose 59.2K in August according to the Labour Force Survey. That was well above consensus expectations which were at just +20K. The job gains were so strong that the...

The share price of Tata Motors has shot up today (September 10th) after it was announced its subsidiary Jaguar Land Rover (JLR) is making a major investment in the UK. It is set to create 1,700 new...

Today the market will be more nervous than it was on Monday. The US is ready to accept Russia's offer and to postpone military operation against Syria, if Syria will agree to transfer it's chemical...

The dollar eases further as tapering fears recedeOnce again the dollar weakened against all the currencies we track, both the G10 and EM currencies, as expectations of higher interest rates in the US...

CurrenciesThe euro reached to higher highs touching 1.3266. The single currency looks to have clearly reversed last week’s bearish trend reaching for new highs.The US dollar remains range bound...

The case for optimism on the outlook for the Eurozone’s nascent economic recovery will be in the crosshairs again today with the July update on industrial production for France. Later, two...

EquitiesAAII survey readings came in at 36% bulls and 31% bears. Bullish readings rose by 2% while bearish readings rose by 1%. The AAII bull ratio (4 week average) currently stands at 5%, which...

The U.S. unemployment data released last week was bitter-sweet news. Whilst the unemployment rate fell to the lowest levels since December 2008 at 7.3%, the result was due to a fall in the...

We welcome the return of the Survey of Leading Economic Bloggers. Tim Kane spearheaded the survey during his Kauffman Foundation tenure. Tim has moved to the Hudson Institute, where he has busily been...

AstraZeneca (AZN) recently announced that it has started enrolling patients for the phase III SOLO (Study of OLaparib in Ovarian cancer) program for its oncology candidate, olaparib. The SOLO program...